VITamin D supplementation in renAL transplant recipients (VITALE): A prospective, multicentre, double-blind, randomized trial of vitamin D estimating the benefit and safety of vitamin D3 treatment at a dose of 100,000 UI compared with a dose of 12,000 UI in renal transplant recipients: Study protocol for a double-blind, randomized, controlled trial

Trials

Volumn 15, Issue 1, 2014, Pages

  Courbebaisse, Marie ^a,b   Alberti, Corinne ^b,c   Colas, Sandra ^d   Prié, Dominique ^b,d   Souberbielle, Jean Claude ^d   Treluyer, Jean Marc ^b,d   Thervet, Eric ^a,b  

^a HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c HÔPITAL ROBERT DEBRÉ   (France)

^d HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

Cancer; Cardiovascular events; Diabetes mellitus; Interventional trial; Renal transplantation; Vitamin D

Indexed keywords

25 HYDROXYVITAMIN D; COLECALCIFEROL; 25-HYDROXYVITAMIN D; BIOLOGICAL MARKER; VITAMIN D;

ACUTE GRAFT REJECTION; ARTICLE; BLOOD PRESSURE REGULATION; BONE DENSITY; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; DIABETES MELLITUS; DOUBLE BLIND PROCEDURE; DRUG DOSE COMPARISON; DRUG EFFICACY; DRUG MEGADOSE; DRUG SAFETY; ECHOCARDIOGRAPHY; FOLLOW UP; FRACTURE; GLOMERULUS FILTRATION RATE; GRAFT RECIPIENT; GRAFT SURVIVAL; HUMAN; INCIDENCE; KIDNEY ALLOGRAFT; KIDNEY GRAFT; LOW DRUG DOSE; MINERAL METABOLISM; MULTICENTER STUDY; NEOPLASM; PROSPECTIVE STUDY; PROTEINURIA; RANDOMIZED CONTROLLED TRIAL; RISK BENEFIT ANALYSIS; VITAMIN D DEFICIENCY; VITAMIN SUPPLEMENTATION; ADVERSE EFFECTS; ANALOGS AND DERIVATIVES; BLOOD; CLINICAL PROTOCOL; CLINICAL TRIAL; COMPARATIVE STUDY; DIET SUPPLEMENTATION; DRUG ADMINISTRATION; FRANCE; KIDNEY TRANSPLANTATION; METHODOLOGY; POSTOPERATIVE COMPLICATIONS; TIME; TREATMENT OUTCOME;

BIOLOGICAL MARKERS; CHOLECALCIFEROL; CLINICAL PROTOCOLS; DIETARY SUPPLEMENTS; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; HUMANS; KIDNEY TRANSPLANTATION; PARIS; POSTOPERATIVE COMPLICATIONS; PROSPECTIVE STUDIES; RESEARCH DESIGN; TIME FACTORS; TREATMENT OUTCOME; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 84920850320     PISSN: None     EISSN: 17456215     Source Type: Journal    
DOI: 10.1186/1745-6215-15-430     Document Type: Article

References (111)

1. Palmer SC, McGregor DO, Strippoli GF: Interventions for preventing bone disease in kidney transplant recipients. Cochrane Database Syst Rev 2007, 18:CD005015.
2. De Sevaux RG, Hoitsma AJ, Corstens FH, Wetzels JF: Treatment with vitamin D and calcium reduces bone loss after renal transplantation: a randomized study. J Am Soc Nephrol 2002, 13:1608-1614.
3. El-Agroudy AE, El-Husseini AA, El-Sayed M, Mohsen T, Ghoneim MA: A prospective randomized study for prevention of postrenal transplantation bone loss. Kidney Int 2005, 67:2039-2045.
4. Torres A, Garcia S, Gomez A, Gonzalez A, Barrios Y, Concepcion MT, Hernandez D, Garcia JJ, Checa MD, Lorenzo V, Salido E: Treatment with intermittent calcitriol and calcium reduces bone loss after renal transplantation. Kidney Int 2004, 65:705-712.
5. Dawson-Hughes B, Heaney RP, Holick MF, Lips P, Meunier PJ, Vieth R: Estimates of optimal vitamin D status. Osteoporos Int 2005, 16:713-716.
6. Heaney RP: Vitamin D depletion and effective calcium absorption. J Bone Miner Res 2003, 18:1342-1343.
7. Bischoff-Ferrari HA, Giovannucci E, Willett WC, Dietrich T, Dawson-Hughes B: Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes. Am J Clin Nutr 2006, 84:18-28.
8. Courbebaisse M, Souberbielle JC, Thervet E: Potential nonclassical effects of vitamin D in transplant recipients. Transplantation 2010, 89:131-137.
9. Pascussi JM, Robert A, Nguyen M, Walrant-Debray O, Garabedian M, Martin P, Pineau T, Saric J, Navarro F, Maurel P, Vilarem MJ: Possible involvement of pregnane X receptor-enhanced CYP24 expression in drug-induced osteomalacia. J Clin Invest 2005, 115:177-186.
10. Bhan I, Shah A, Holmes J, Isakova T, Gutierrez O, Burnett SM, Juppner H, Wolf M: Post-transplant hypophosphatemia: tertiary 'hyper-phosphatoninism'? Kidney Int 2006, 70:1486-1494.
11. Reichrath J: Dermatologic management, sun avoidance and vitamin D status in organ transplant recipients (OTR). J Photochem Photobiol B 2012, 101:150-159.
12. Courbebaisse M, Thervet E, Souberbielle JC, Zuber J, Eladari D, Martinez F, Mamzer-Bruneel MF, Urena P, Legendre C, Friedlander G, Prie D: Effects of vitamin D supplementation on the calcium-phosphate balance in renal transplant patients. Kidney Int 2009, 75:646-651.
13. Wissing KM, Broeders N, Moreno-Reyes R, Gervy C, Stallenberg B, Abramowicz D: A controlled study of vitamin D3 to prevent bone loss in renal-transplant patients receiving low doses of steroids. Transplantation 2005, 79:108-115.
14. Benaboud S, Urien S, Thervet E, Prié D, Legendre C, Souberbielle JC, Hirt D, Friedlander G, Treluyer JM, Courbebaisse M: Determination of optimal cholecalciferol treatment in renal transplant recipients using a population pharmacokinetic approach. Eur J Clin Pharmacol 2013, 69:499-506.
15. Kasiske BL, Snyder JJ, Gilbertson DT, Wang C: Cancer after kidney transplantation in the United States. Am J Transplant 2004, 4:905-913.
16. Liu M, Lee MH, Cohen M, Bommakanti M, Freedman LP: Transcriptional activation of the Cdk inhibitor p21 by vitamin D3 leads to the induced differentiation of the myelomonocytic cell line U937. Genes Dev 1996, 10:142-153.
17. Díaz GD, Paraskeva C, Thomas MG, Binderup L, Hague A: Apoptosis is induced by the active metabolite of vitamin D3 and its analogue EB1089 in colorectal adenoma and carcinoma cells: possible implications for prevention and therapy. Cancer Res 2000, 60:2304-2312.
18. Tangpricha V, Flanagan JN, Whitlatch LW, Tseng CC, Chen TC, Holt PR, Lipkin MS, Holick MF: 25-hydroxyvitamin D-1alpha-hydroxylase in normal and malignant colon tissue. Lancet 2001, 357:1673-1674.
19. Mantell DJ, Owens PE, Bundred NJ, Mawer EB, Canfield AE: 1 alpha, 25-dihydroxyvitamin D(3) inhibits angiogenesis in vitro and in vivo. Circ Res 2000, 87:214-220.
20. Fleet JC: Molecular actions of vitamin D contributing to cancer prevention. Mol Aspects Med 2008, 29:388-396.
21. Touvier M, Chan DS, Lau R, Aune D, Vieira R, Greenwood DC, Kampman E, Riboli E, Hercberg S, Norat T: Meta-analyses of vitamin D intake, 25-hydroxyvitamin D status, vitamin D receptor polymorphisms, and colorectal cancer risk. Cancer Epidemiol Biomarkers Prev 2011, 20:1003-1016.
22. Chen P, Hu P, Xie D, Qin Y, Wang F, Wang H: Meta-analysis of vitamin D, calcium and the prevention of breast cancer. Breast Cancer Res Treat 2010, 121:469-477.
23. Polesel J, Talamini R, Montella M, Parpinel M, Dal Maso L, Crispo A, Crovatto M, Spina M, La Vecchia C, Franceschi S: Linoleic acid, vitamin D and other nutrient intakes in the risk of non-Hodgkin lymphoma: an Italian case-control study. Ann Oncol 2006, 17:713-718.
24. Soni LK, Hou L, Gapstur SM, Evens AM, Weisenburger DD, Chiu BC: Sun exposure and non-Hodgkin lymphoma: a population-based, case-control study. Eur J Cancer 2007, 43:2388-2395.
25. Tretli S, Hernes E, Berg JP, Hestvik UE, Robsahm TE: Association between serum 25(OH)D and death from prostate cancer. Br J Cancer 2009, 100:450-454.
26. Ren C, Qiu MZ, Wang DS, Luo HY, Zhang DS, Wang ZQ, Wang FH, Li YH, Zhou ZW, Xu RH: Prognostic effects of 25-hydroxyvitamin D levels in gastric cancer. J Transl Med 2012, 10:16.
27. Fedirko V, Riboli E, Tjønneland A, Ferrari P, Olsen A, Bueno-de-Mesquita HB, van Duijnhoven FJ, Norat T, Jansen EH, Dahm CC, Overvad K, Boutron-Ruault MC, Clavel-Chapelon F, Racine A, Lukanova A, Teucher B, Boeing H, Aleksandrova K, Trichopoulou A, Benetou V, Trichopoulos D, Grioni S, Vineis P, Panico S, Palli D, Tumino R, Siersema PD, Peeters PH, Skeie G, Brustad M, et al.: Prediagnostic 25-hydroxyvitamin D, VDR and CASR polymorphisms, and survival in patients with colorectal cancer in western European populations. Cancer Epidemiol Biomarkers Prev 2012, 21:582-593.
28. Tuohimaa P, Tenkanen L, Ahonen M, Lumme S, Jellum E, Hallmans G, Stattin P, Harvei S, Hakulinen T, Luostarinen T, Dillner J, Lehtinen M, Hakama M: Both high and low levels of blood vitamin D are associated with a higher prostate cancer risk: a longitudinal, nested case-control study in the Nordic countries. Int J Cancer 2004, 108:104-108.
29. Stolzenberg-Solomon RZ, Jacobs EJ, Arslan AA, Qi D, Patel AV, Helzlsouer KJ, Weinstein SJ, McCullough ML, Purdue MP, Shu XO, Snyder K, Virtamo J, Wilkins LR, Yu K, Zeleniuch-Jacquotte A, Zheng W, Albanes D, Cai Q, Harvey C, Hayes R, Clipp S, Horst RL, Irish L, Koenig K, Le Marchand L, Kolonel LN: Circulating 25-hydroxyvitamin D and risk of pancreatic cancer: Cohort Consortium Vitamin D Pooling Project of Rarer Cancers. Am J Epidemiol 2010, 172:81-93.
30. Wactawski Wende J, Kotchen JM, Anderson GL, Assaf AR, Brunner RL, O'Sullivan MJ, Margolis KL, Ockene JK, Phillips L, Pottern L, Prentice RL, Robbins J, Rohan TE, Sarto GE, Sharma S, Stefanick ML, Van Horn L, Wallace RB, Whitlock E, Bassford T, Beresford SA, Black HR, Bonds DE, Brzyski RG, Caan B, Chlebowski RT, Cochrane B, Garland C, Gass M, Hays J, et al.: Calcium plus vitamin D supplementation and the risk of colorectal cancer. N Engl J Med 2006, 354:684-696.
31. Bolland MJ, Grey A, Gamble GD, Reid IR: Calcium and vitamin D supplements and health outcomes: a reanalysis of the Women's Health Initiative (WHI) limited-access dataset. Am J Clin Nutr 2011, 94:1144-1149.
32. Lappe JM, Travers-Gustafson D, Davies KM, Recker RR, Heaney RP: Vitamin D and calcium supplementation reduces cancer risk: results of a randomized trial. Am J Clin Nutr 2007, 85:1586-1591.
33. Avenell A, MacLennan GS, Jenkinson DJ, McPherson GC, McDonald AM, Pant PR, Grant AM, Campbell MK, Anderson FH, Cooper C, Francis RM, Gillespie WJ, Robinson CM, Torgerson DJ, Wallace WA, RECORD Trial Group: Long-term follow-up for mortality and cancer in a randomized placebo-controlled trial of vitamin D(3) and/or calcium (RECORD trial). J Clin Endocrinol Metab 2012, 97:614-622.
34. Ducloux D, Courivaud C, Bamoulid J, Kazory A, Dumoulin G, Chalopin JM: Pretransplant serum vitamin D levels and risk of cancer after renal transplantation. Transplantation 2008, 85:1755-1759.
35. Marcén R, Jimenez S, Fernández-Rodriguez A, Galeano C, Villafruela JJ, Gomis A, Teruel JL, Quereda C: Are low levels of 25-hydroxyvitamin D a risk factor for cardiovascular diseases or malignancies in renal transplantation? Nephrol Dial Transplant 2012,27(Suppl 4):47-52.
36. Obi Y, Ichimaru N, Hamano T, Tomida K, Matsui I, Fujii N, Okumi M, Kaimori JY, Yazawa K, Kokado Y, Tsubakihara Y, Nonomura N, Rakugi H, Takahara SIY: Orally active vitamin D for potential chemoprevention of posttransplant malignancy. Cancer Prev Res 2012, 5:1229-1235.
37. Ellison TI, Smith MK, Gilliam AC, MacDonald PN: Inactivation of the vitamin D receptor enhances susceptibility of murine skin to UV-induced tumorigenesis. J Invest Dermatol 2008, 128:2508-2517.
38. Ulrich C, Jürgensen JS, Degen A, Hackethal M, Ulrich M, Patel MJ, Eberle J, Terhorst D, Sterry WSE: Prevention of non-melanoma skin cancer in organ transplant patients by regular use of a sunscreen: a 24 months, prospective, case-control study. Br J Dermatol 2009,161(Suppl 3):78-84.
39. Penny H, Frame S, Dickinson F, Garrett G, Young AR, Sarkany R, Chitalia N, Hampson G, Goldsmith D: Determinants of vitamin D status in long-term renal transplant patients. Clin Transplant 2012, 26:617-623.
40. Montori VM, Basu A, Erwin PJ, Velosa JA, Gabriel SE, Kudva YC: Posttransplantation diabetes: a systematic review of the literature. Diabetes Care 2002, 25:583-592.
41. Pittas AG, Lau J, Hu FB, Dawson-Hughes B: The role of vitamin D and calcium in type 2 diabetes: a systematic review and meta-analysis. J Clin Endocrinol Metab 2007, 92:2017-2029.
42. Johnson JA, Grande JP, Roche PC, Kumar R: Immunohistochemical localization of the 1,25(OH)2D3 receptor and calbindin D28k in human and rat pancreas. Am J Physiol 1994, 267:356-360.
43. Bland R, Markovic D, Hills CE, Hughes SV, Chan SL, Squires PE, Hewison M: Expression of 25-hydroxyvitamin D3-1alpha-hydroxylase in pancreatic islets. J Steroid Biochem Mol Biol 2004, 89-90:121-125.
44. Maestro B, Dávila N, Carranza MC, Calle C: Identification of a Vitamin D response element in the human insulin receptor gene promoter. J Steroid Biochem Mol Biol 2003, 84:223-230.
45. Zeitz U, Weber K, Soegiarto DW, Wolf E, Balling R, Erben RG: Impaired insulin secretory capacity in mice lacking a functional vitamin D receptor. FASEB J 2003, 17:509-511.
46. Cade C, Norman AW: Vitamin D3 improves impaired glucose tolerance and insulin secretion in the vitamin D-deficient rat in vivo. Endocrinology 1986, 119:84-90.
47. Scragg R, Sowers M, Bell C: Serum 25-hydroxyvitamin D, diabetes, and ethnicity in the third national health and nutrition examination survey. Diabetes Care 2004, 27:2813-2818.
48. Afzal S, Bojesen SE, Nordestgaard BG: Low 25-hydroxyvitamin D and risk of type 2 diabetes: a prospective cohort study and metaanalysis. ClinChem 2013, 59:381-391.
49. Song Y, Wang L, Pittas AG, Del Gobbo LC, Zhang C, Manson JE, Hu FB: Blood 25-hydroxyvitamin D levels and incident type 2 diabetes: a meta-analysis of prospective studies. Diabetes Care 2013, 36:1422-1428.
50. Hypponen E, Power C: Vitamin D status and glucose homeostasis in the 1958 British birth cohort: the role of obesity. Diabetes Care 2006, 29:2244-2246.
51. Sun X, Zemel MB: Calcium and 1,25-dihydroxyvitamin D3 regulation of adipokine expression. Obesity (Silver Spring) 2007, 15:340-348.
52. Tabesh M, Azadbakht L, Faghihimani E, Tabesh M, Esmaillzadeh A: Calcium-vitamin D co-supplementation influences circulating inflammatory biomarkers and adipocytokines in vitamin D insufficient diabetics: a randomized controlled clinical trial. J Clin Endocrinol Metab 2014, 12:jc20141977.
53. George PS, Pearson ER, Witham MD: Effect of vitamin D supplementation on glycaemic control and insulin resistance: a systematic review and meta-analysis. Diabet Med 2012, 29:142-150.
54. Seida JC, Mitri J, Colmers IN, Majumdar SR, Davidson MB, Edwards AL, Hanley DA, Pittas AG, Tjosvold L, Johnson JA: Effect of vitamin D3 supplementation on improving glucose homeostasis and preventing diabetes: a systematic review and meta-analysis. J Clin Endocrinol Metab 2014, 25:jc20142136.
55. Sarnak MJ, Levey AS, Schoolwerth AC, Coresh J, Culleton B, Hamm LL, McCullough PA, Kasiske BL, Kelepouris E, Klag MJ, Parfrey P, Pfeffer M, Raij L, Spinosa DJ, Wilson PW: American heart association councils on kidney in cardiovascular disease, high blood pressure research, clinical cardiology, and epidemiology and prevention: kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on kidney in cardiovascular disease, high blood pressure research, clinical cardiology, and epidemiology and prevention. Hypertension 2003, 42:1050-1065.
56. London GM, Guérin AP, Verbeke FH, Pannier B, Boutouyrie P, Marchais SJ, Mëtivier F: Mineral metabolism and arterial functions in end-stage renal disease: potential role of 25-hydroxyvitamin D deficiency. J Am Soc Nephrol 2007, 18:613-620.
57. Wang TJ, Pencina MJ, Booth SL, Jacques PF, Ingelsson E, Lanier K, Benjamin EJ, D'Agostino RB, Wolf M, Vasan RS: Vitamin D deficiency and risk of cardiovascular disease. Circulation 2008, 117:503-511.
58. Giovannucci E, Liu Y, Hollis BW, Rimm EB: 25-hydroxyvitamin D and risk of myocardial infarction in men: a prospective study. Arch Intern Med 2008, 168:1174-1180.
59. Pilz S, Dobnig H, Nijpels G, Heine RJ, Stehouwer CD, Snijder MB, Van Dam RM, Dekker JM: Vitamin D and mortality in older men and women. Clin Endocrinol (Oxf) 2009, 71:666-672.
60. Pilz S, März W, Wellnitz B, Seelhorst U, Fahrleitner-Pammer A, Dimai HP, Boehm BO, Dobnig H: Association of vitamin D deficiency with heart failure and sudden cardiac death in a large cross-sectional study of patients referred for coronary angiography. J Clin Endocrinol Metab 2008, 93:3927-3935.
61. Dobnig H, Pilz S, Scharnagl H, Renner W, Seelhorst U, Wellnitz B, Kinkeldei J, Boehm BO, Weihrauch G, Maerz W: Independent association of low serum 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D levels with all-cause and cardiovascular mortality. Arch Intern Med 2008, 168:1340-1349.
62. Khaw KT, Luben R, Wareham N: Serum 25-hydroxyvitamin D, mortality, and incident cardiovascular disease, respiratory disease, cancers, and fractures: a 13-y prospective population study. Am J ClinNutr 2014. doi: 10.3945/ajcn.114.086413
63. Zittermann A, Schleithoff SS, Koerfer R: Putting cardiovascular disease and vitamin D insufficiency into perspective. Br J Nutr 2005, 94:483-492.
64. Wu J, Garami M, Cheng T, Gardner DG: 1,25(OH)2 vitamin D3, and retinoic acid antagonize endothelin-stimulated hypertrophy of neonatal rat cardiac myocytes. J Clin Invest 1996, 97:1577-1588.
65. Nibbelink KA, Tishkoff DX, Hershey SD, Rahman A, Simpson RU: 1,25(OH)2-vitamin D3 actions on cell proliferation, size, gene expression, and receptor localization, in the HL-1 cardiac myocyte. J Steroid Biochem Mol Biol 2007, 103:533-537.
66. Cardús A, Parisi E, Gallego C, Aldea M, Fernández E, Valdivielso JM: 1,25-Dihydroxyvitamin D3 stimulates vascular smooth muscle cell proliferation through a VEGF-mediated pathway. Kidney Int 2006, 69:1377-1384.
67. Green JJ, Robinson DA, Wilson GE, Simpson RU, Westfall MV: Calcitriol modulation of cardiac contractile performance via protein kinase C. J Mol Cell Cardiol 2006, 41:350-359.
68. Tishkoff DX, Nibbelink KA, Holmberg KH, Dandu L, Simpson RU: Functional vitamin D receptor (VDR) in the t-tubules of cardiac myocytes: VDR knockout cardiomyocytecontractility. Endocrinology 2008, 149:558-564.
69. Bouillon R, Carmeliet G, Verlinden L, van Etten E, Verstuyf A, Luderer HF, Lieben L, Mathieu C, Demay M: Vitamin D and human health: Lessons from vitamin D receptor null mice. Endocr Rev 2008, 29:726-776.
70. Zhou C, Lu F, Cao K, Xu D, Goltzman D, Miao D: Calcium-independent and 1,25(OH)2D3-dependent regulation of the renin-angiotensin system in 1alpha-hydroxylase knockout mice. Kidney Int 2008, 74:170-179.
71. Halder SK, Osteen KG, Al-Hendy A: Vitamin D3 inhibits expression and activities of matrix metalloproteinase-2 and -9 in human uterine fibroid cells. Hum Reprod 2013, 28:2407-2416.
72. Basalyga DM, Simionescu DT, Xiong W, Baxter BT, Starcher BC, Vyavahare NR: Elastin degradation and calcification in an abdominal aorta injury model: Role of matrix metalloproteinases. Circulation 2004, 110:3480-3487.
73. Vimaleswaran KS, Cavadino A, Berry DJ, Jorde R, Dieffenbach AK, Lu C, Alves AC, Heerspink HJ, Tikkanen E, Eriksson J, Wong A, Mangino M, Jablonski KA, Nolte IM, Houston DK, Ahluwalia TS, van der Most PJ, Pasko D, Zgaga L, Thiering E, Vitart V, Fraser RM, Huffman JE, de Boer RA, Schöttker B, Saum KU, McCarthy MI, Dupuis J, Herzig KH, Sebert S, et al.: Association of vitamin D status with arterial blood pressure and hypertension risk: a mendelian randomisation study. Lancet Diabetes Endocrinol 2014,2(9):719-729.
74. Ku YC, Liu ME, Ku CS, Liu TY, Lin SL: Relationship between vitamin D deficiency and cardiovascular disease. World J Cardiol 2013, 5:337-346.
75. Witham MD, Nadir MA, Struthers AD: Effect of vitamin D on blood pressure: a systematic review and meta-analysis. J Hypertens 2009, 27:1948-1954.
76. Larsen T, Mose FH, Bech JN, Hansen AB, Pedersen EB: Effect of cholecalciferol supplementation during winter months in patients with hypertension: a randomized, placebo-controlled trial. Am J Hypertens 2012, 25:1215-1222.
77. Ford JA, MacLennan GS, Avenell A, Bolland M, Grey A, Witham M, RECORD Trial Group: Cardiovascular disease and vitamin D supplementation: trial analysis, systematic review, and meta-analysis. Am J Clin Nutr 2014, 100:746-755.
78. Bolland M, Grey A, Gamble G, Reid I: The effect of vitamin D supplementation on skeletal, vascular, or cancer outcomes: a trial sequential meta-analysis. Lancet Diabetes Endocrinol 2014, 2:307-320.
79. Autier P, Boniol M, Pizot C, Mullie P: Vitamin D and ill health: a systematic review. Lancet Diabetes Endocrinol 2014, 2:76-89.
80. Chowdhury R, Kunutsor S, Vitezova A, Oliver Williams C, Chowdhury S, Kiefte De Jong JC, Khan H, Baena CP, Prabhakaran D, Hoshen MB, Feldman BS, Pan A, Johnson L, Crowe F, Hu FB, Franco OH: Vitamin D and risk of cause specific death: systematic review and meta-analysis of observational studies and randomised intervention studies. BMJ 2014, 1:348-g1903.
81. Bjelakovic G, Gluud LL, Nikolova D, Whitfield K, Wetterslev J, Simonetti RG, Bjelakovic M, Gluud C: Vitamin D supplementation for prevention of mortality in adults. Cochrane Database Syst Rev 2014,10(1):CD007470.
82. Lee DR, Kong JM, Cho KI, Chan L: Impact of vitamin D on proteinuria, insulin resistance, and cardiovascular parameters in kidney transplant recipients. Transplant Proc Elsevier Inc 2011, 43:3723-3729.
83. Shroff R, Knott C, Gullett A, Wells D, Marks SD, Rees L: Vitamin D deficiency is associated with short stature and may influence blood pressure control in paediatric renal transplant recipients. Pediatr Nephrol 2011, 26:2227-2233.
84. Zittermann A, Schleithoff SS, Koerfer R: Vitamin D and vascular calcification. Curr Op in Lipidol 2007, 18:41-46.
85. Durup D, Jørgensen HL, Christensen J, Schwarz P, Heegaard AM, Lind B: A reverse J-shaped association of all-cause mortality with serum 25-hydroxyvitamin D in general practice: the CopD study. J Clin Endocrinol Metab 2012, 97:2644-2652.
86. Dror Y, Giveon SM, Hoshen M, Feldhamer I, Balicer RD, Feldman BS: Vitamin D levels for preventing acute coronary syndrome and mortality: evidence of a nonlinear association. J Clin Endocrinol Metab 2013, 98:2160-2167.
87. Zittermann A, Kuhn J, Dreier J, Knabbe C, Gummert JF, Börgermann J: Vitamin D status and the risk of major adverse cardiac and cerebrovascular events in cardiac surgery. Eur Heart J 2013, 34:1358-1364.
88. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D, Modification of Diet in Renal Disease Study Group: A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Ann Intern Med 1999, 130:461-470.
89. Pilz S, Kienreich K, Tomaschitz A, Lerchbaum E, Meinitzer A, März W, Zittermann A, Dekker JM: Vitamin D and cardiovascular disease: update and outlook. Scand J Clin Lab Invest Suppl 2012, 243:83-91.
90. Zitterman A: Vitamin D and cardiovascular disease. Anticancer Res 2014, 34:4641-4648.
91. Kasiske BL, Snyder JJ, Gilbertson D, Matas AJ: Diabetes mellitus after kidney transplantation in the United States. Am J Transplant 2003, 3:178-185.
92. Hjelmesaeth J, Hartmann A, Leivestad T, Holdaas H, Sagedal S, Olstad M, Jenssen T: The impact of early-diagnosed new-onset post-transplantation diabetes mellitus on survival and major cardiac events. Kidney Int 2006, 69:588-595.
93. Holdaas H, Fellstrom B, Jardine AG, Holme I, Nyberg G, Fauchald P, Gronhagen-Riska C, Madsen S, Neumayer HH, Cole E, Maes B, Ambuhl P, Olsson AG, Hartmann A, Solbu DO, Pedersen TR: Effect of fluvastatin on cardiac outcomes in renal transplant recipients: a multicentre, randomised, placebo-controlled trial. Lancet 2003, 361:2024-2031.
94. Kasiske BL, Guijarro C, Massy ZA, Wiederkehr MR, Ma JZ: Cardiovascular disease after renal transplantation. J Am SocNephrol 1996, 7:158-165.
95. Courivaud C, Kazory A, Simula-Faivre D, Chalopin JM, Ducloux D: Metabolic syndrome and atherosclerotic events in renal transplant recipients. Transplantation 2007, 83:1577-1581.
96. Kessler M, Jay N, Molle R, Guillemin F: Excess risk of cancer in renal transplant patients. Transpl Int 2006, 19:908-914.
97. Raimundo FV, Faulhaber GA, Menegatti PK, Marques Lda S, Furlanetto TW: Effect of high- versus low-fat meal on serum 25-hydroxyvitamin D levels after a single oral dose of vitamin D: a single-blind, parallel, randomized trial. Int J Endocrinol 2011, 2011:809069.
98. Martin A: Apports nutritionnels conseillés pour la population française (3ème édition). Londres, Paris, New York: TEC et DOC; 2001:605.
99. Holick MF: Resurrection of vitamin D deficiency and rickets. J Clin Invest 2006, 116:2062-2072.
100. Hollis BW, Kamerud JQ, Selvaag SR, Lorenz JD, Napoli JL: Determination of vitamin D status by radioimmunoassay with an 125I-labeled tracer. Clin Chem 1993, 39:529-533.
101. Stepman H, Vanderroost A, VanUytfanghe K, Thienpont L: Candidate reference measurement procedures for serum 25-hydroxyvitamin D3 and 25-hydroxyvitamin D2 by using isotope-dilution liquid chromatography-tandem mass spectrometry. Clin Chem 2011, 57:441-448.
102. Sempos C, Vesper HW, Phinney KW, Thienpont L, Coates PM: Vitamin D status as an international issue: national surveys and the problem of standardization. Scand J Clin Lab 2012, 243:32-40.
103. Cavalier E, Lukas P, Crine Y, Peeters S, Carlisi A, Le Goff C, Gadisseur R, Delanaye P, Souberbielle JC: Evaluation of automated immunoassays for 25(OH)-vitamin D determination in different critical populations before and after standardization of the assays. Clin Chim Acta 2014, 431:60-65.
104. Vieth R: Vitamin D toxicity, policy, and science. J Bone Miner Res 2007, 22:64-68.
105. Barger-Lux MJ, Heaney RP: Effects of above average summer sun exposure on serum 25-hydroxyvitamin D and calcium absorption. J Clin Endocrinol Metab 2002, 87:4952-4956.
106. Heaney RP, Davies KM, Chen TC, Holick MF, Barger-Lux MJ: Human serum 25-hydroxycholecalciferol response to extended oral dosing with cholecalciferol. Am J Clin Nutr 2003, 77:204-210.
107. Przybelski R, Agrawal S, Krueger D, Engelke JA, Walbrun F, Binkley N: Rapid correction of low vitamin D status in nursing home residents. Osteoporos Int 2008, 19:1621-1628.
108. Vieth R, Chan PC, MacFarlane GD: Efficacy and safety of vitamin D3 intake exceeding the lowest observed adverse effect level. Am J Clin Nutr 2001, 73:288-294.
109. Romagnoli E, Mascia ML, Cipriani C, Fassino V, Mazzei F, D'Erasmo E, Carnevale V, Scillitani A, Minisola S: Short and long-term variations in serum calciotropic hormones after a single very large dose of ergocalciferol (vitamin D2) or cholecalciferol (vitamin D3) in the elderly. J Clin Endocrinol Metab 2008, 93:3015-3020.
110. McGregor R, Li G, Penny H, Lombardi G, Afzali B, Goldsmith D: Vitamin D in renal transplantation - from biological mechanisms to clinical benefits. Am J Transplant 2014, 14:1259-1270.
111. Thiem U, Heinze G, Segel R, Perkmann T, Kainberger F, Mühlbacher F, Hörl W, Borchhardt K: VITA-D: cholecalciferol substitution in vitamin D deficient kidney transplant recipients: a randomized, placebo-controlled study to evaluate the post-transplant outcome. Trials 2009, 10:36.